This study provides direct evidence on the anti‐ferroptotic roles of HCAR1 and MCT1 in tumor cells, highlighting their potential applications as molecular targets for ferroptosis‐based HCC therapy.[125]. This evidence concerns the gene HCAR1 and hepatocellular carcinoma.